Mankind Pharma combats leprosy, partners with Lepra Society to screen 80,000 individuals
Mankind Pharma, a leading pharmaceutical company in India, has announced a strategic partnership with the Lepra Society to launch a comprehensive initiative aimed at eradicating, raising awareness, and treating leprosy. Under their CSR arm, the company is committed to making a meaningful impact in regions affected by leprosy, and as part of this commitment, they have established five exclusive Comprehensive Disability Care Centres (CDCC) across different locations.
• The CDCCs are strategically positioned in regions identified as high-impact areas, including the NTR District in Andhra Pradesh, Guru Gobind Hospital in Delhi, the Government Hospital in Chandarpur, Maharashtra, the Community Care Centre in Odisha, Koraput, and Nirmal District in Telangana.
• These centres are operational throughout the year, addressing various issues related to leprosy and elephantiasis.
• The company aims to provide essential treatment and raise awareness through these centres, collaborating closely with the Lepra Society.
Sheetal Arora, CEO, Mankind Pharma, said, “Our partnership with the Lepra Society is a step forward in our mission to eradicate leprosy and create awareness. The CDCCs in key regions will play a crucial role in providing treatment and support to those affected by leprosy. We hope that the targeted communities will benefit from this renewed focus on leprosy.
Mankind Pharma will undertake a range of vital activities to combat leprosy and its socio-economic impacts. Over 80,000 individuals will undergo comprehensive screening, accompanied by extensive awareness programme designed to educate and inform communities.
Additionally, the initiative aims to provide treatment to more than 6,000 patients through the morbidity management and disability programme, showcasing the commitment to holistic care. Over 10 reconstructive surgeries are slated to take place, aimed at restoring normalcy for affected individuals. It will also extend socio-economic support to over 400 families, addressing the multi-faceted challenges faced by communities.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!